1[1]Holmstrom M, Hanninen H, Simpanen J, et al. Wall motion and perfusion analy-sis of transmyocardial laser revascularization. Scand Cardiovasc J, 2003,37(2): 91-97.
2[2]Arora RC, Hirsch K.Transmyocardial laser revascularization remodels the intrinsic cardiac nervous system in a chronic setting. Ciculation, 2001,104( 12 Suppl 1 ): S1115-S1130.
3[3]Gray TJ,Burns SM,Clarke SC,et al. Percutaneous myocardial laser revascular-ization in patients with refractory angina pectoris. Am J Cardiol, 2003,91 (6): 661-666.
4[4]Schratzberger P, Kirchmair R, Vale PR, et al.Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. Curt Pharm Des, 2003,9(12): 104 1-1047.
6[6]Komowski R, Leon MB, Fuchs S, et al. Electromagnetic guidance for catheter-based transendocardial injection:apltform for intramyocardia. Coll Cardiol, 2000,35 (4):1031-1039.
7[7]Miyamoto MI,Monte F,Schmidt U,et al. Adenoviralgene transfer of SERCA2 aimproves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acard Sci USA, 2000, 101 (2): 2554-2557.
8[8]Heeschen C, Dimmeles S, Hamm CW, et al. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation,2003,107(4) :524-530.
9[9]Silvestre JS,Levy BI.Angiogenesis therapy in ischwmic disease. Arch Mal Coeur Vaiss, 2002,95 (3): 189-196
